TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RANI

Rani Therapeutics Holdings Inc

Healthcare · Biotechnology

0.7611$ +1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RANI
Line item 2019 2020 2021 2022 2023 2024 2025
-2,683.0% -3,238.1% -1,186.8% – – -3,452.9% -1,146.0%
57.6% 127.5% 18.3% – – 100.0% 55.1%
– 0.0% 831.6% – – 1,559.4% 722.5%
-8.3% 23.8% -772.2% – – – –
-16.6% 226.0% -126.2% – – -52.9% 426.1%
161.5% 259.7% 18.6% – – 26.1% 5.4%
-156.5% -259.7% -18.6% – – 1,926.9% -430.5%
– – – – – 29.6% –
412.2% 873.4% -168.1% – – -486.4% -1,269.0%
87.0% 15,732.0% 2,839.4% – – 1,321.5% 2,467.9%
-2,752.5% 12,234.2% 1,634.0% – – -204.5% 891.4%
-2,844.5% -3,497.8% -1,205.4% – – -3,479.0% -1,151.4%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?